Aflibercept Zaltrap IV 100mg Injection is a medication used to treat certain types of cancer, primarily metastatic colorectal cancer (mCRC) and other solid tumors. Aflibercept Zaltrap IV 100mg Injection contains aflibercept, a recombinant fusion protein that acts as a VEGF (vascular endothelial growth factor) inhibitor. By blocking VEGF, Aflibercept prevents the formation of new blood vessels that supply tumors, thereby inhibiting tumor growth and spread. Aflibercept Zaltrap IV 100mg Injection is administered intravenously and is typically used in combination with chemotherapy. As with other anti-VEGF therapies, it may cause side effects, including an increased risk of bleeding, high blood pressure, and delayed wound healing, requiring careful monitoring during treatment.
